Supratentorial Neoplasms
11
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Opioid Free VS Opioid Anesthesia for Craniotomies
Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
Pre- vs. Postoperative Scalp Block for Pain Control After Supratentorial Craniotomy
Effect of PEEP on Subdural Pressure, Optic Nerve Sheath Diameter, Lung Compliance and Brain Perfusion Pressure
Comparison of Efficacy and Safety of the Postoperative Analgesia Methods
Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy
Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial
Mannitol Brain Relaxation Effect
Anaesthesia for Supratentorial Tumor Resection
Scalp Nerve Blocks for Post-Craniotomy Pain